Clin Colon Rectal Surg 2002; 15(2): 139-144
DOI: 10.1055/s-2002-32062
Copyright © 2002 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Polyp Histology and Management

Michael D. Hellinger
  • Division of Colon and Rectal Surgery, DeWitt Daughtry, Department of Surgery, University of Miami School of Medicine, Miami, FL
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
06. Juni 2002 (online)

ABSTRACT

A polyp represents a growth of tissue projecting from the surface of the bowel mucosa. Polyps may be neoplastic or non-neoplastic. The only definitive way to determine the type of polyp is with endoscopic sampling. Because there is a high rate of synchronous polyps, total colonoscopy must be performed. Although the vast majority of adenomas are benign, as they grow their malignant potential increases. In fact some of these polyps are found to harbor cancer. The mainstay of therapy therefore is endoscopic excision. Fewer than 5% of polyps are irretrievable colonoscopically. For these polyps, various surgical options are available. The advent of laparoscopic techniques has made surgical intervention much less invasive, especially when combining both laparoscopy and endoscopy. Medical therapy has focused on polyp prevention. However, treatment with nonsteroidal anti-inflammatory drugs, especially COX-2 inhibitors, has been shown to be effective in inducing polyp regression and inhibiting polyp growth.

REFERENCES

  • 1 Keighley M RB, Williams N S. Surgery of the Anus, Rectum, and Colon.  Philadelphia: WB Saunders 1993: 760-801
  • 2 Gordon P H, Nivatvongs S. Principles and Practice of Surgery for the Colon, Rectum, and Anus, 2nd ed. St Louis, MO: Quality Medical . 1999: 542-569
  • 3 O'Brien M J. Colorectal adenomas: concepts and controversies.  Semin Colon Rectal Surg . 1992;  3 195-206
  • 4 Owen D A, Kelly J K. Atlas of Gastrointestinal Pathology.  Philadelphia: WB Saunders 1994: 168-176
  • 5 Kaye G I, Fenoglio C M, Pascal P R, Lane N. Comparative electron microscopic features of normal hyperplastic and adenomatous human colonic epithelium.  Gastroenterology . 1973;  64 926
  • 6 Fenoglio C M, Richart R M, Kaye G I. Comparative electron microscopic features of normal hyperplastic and adenomatous human colonic epithelium II.  Gastroenterology . 1975;  69 100
  • 7 Kozuka S. Premalignancy of the mucosal polyp in the large intestine.  Dis Colon Rectum . 1975;  18 483
  • 8 Ekelund G, Lindstrom C. Histopathological analysis of benign polyps in patients with carcinoma of the colon and rectum.  Gut . 1974;  15 654
  • 9 Day D W, Morson B C. Pathology of adenomas. In: Morson BD, ed. The Pathogenesis of Colorectal Cancer Philadelphia: WB Saunders 1978: 43-57
  • 10 Morson B C, Dawson M P. Gastrointestinal Pathology, 3rd ed. Oxford: Blackwell Scientific . 1990
  • 11 Muto T, Bussey H JR, Morson B C. Pseudocarcinomatous invasion in adenomatous polyps of the colon and rectum.  J Clin Pathol . 1973;  26 25
  • 12 Muto T, Bussey H JR, Morson B C. The evolution of cancer of the colon and rectum.  Cancer . 1975;  36 2251-2270
  • 13 Grinnell R S, Lane N. Benign and malignant adenomatous polyps and papillary adenomas of the colon and rectum.  Int Abstr Surg . 1958;  106 519-538
  • 14 Nivatvongs S, Goldberg S M. Management of patients who have polyps containing invasive carcinoma removed via colonoscope.  Dis Colon Rectum . 1978;  21 8-11
  • 15 Colacchio T A, Forde K A, Scantlebury V P. Endoscopic polypectomy: inadequate treatment for invasive colorectal carcinoma.  Ann Surg . 1981;  194 704-707
  • 16 Minopoulos G L, McIntyre R LE, Lee E CG, Kettlewell M GW. Colonoscopic polypectomy in a regional teaching hospital.  Br J Surg . 1983;  70 51-53
  • 17 Azimuddin K, Stasik J J, Kubchandani I T. Hyperplastic polyps: more the meets the eye.  Dis Colon Rectum . 2000;  43 1309-1313
  • 18 Raksin J B, Nord H J. Colonoscopy: Principles and Techniques.  New York: Igaku-shoin 1995: 296-309
  • 19 Eijsbouts Q AJ, Heuff G, Sietses C, Meijer S, Cuesta M A. Laparoscopic surgery in the treatment of colonic polyps.  Br J Surg . 1999;  86 505-508
  • 20 Franklin M E, Diaz-E J A, Abrego D, Parra-Davila E, Glass J L. Laparoscopic-assisted colonoscopic polypectomy.  Dis Colon Rectum . 2000;  43 1246-1249
  • 21 Joo J S, Amarnath L, Wexner S D. Is laparoscopic resection of colorectal polyps beneficial?.  Surg Endosc . 1998;  12 1341-1344
  • 22 Prohm P, Weber J, Bonner C. Laparoscopic-assisted colonoscopic polypectomy.  Dis Colon Rectum . 2001;  44 746-748
  • 23 Haggitt R C, Glotzbach R E, Soffer E E, Wruble L D. Prognostic factors in colorectal carcinomas arising in adenomas: implications for lesions removed by endoscopic polypectomy.  Gastroenterology . 1985;  89 328-336
  • 24 Nivatvongs S, Rojanaskul A, Reiman H M. The risk of lymph node metastasis in colorectal polyps with invasive adenocarcinoma.  Dis Colon Rectum . 1991;  34 323
  • 25 Pollard C W, Nivatvongs S, Rojanaskul A. The fate of patients following polypectomy alone for polyps containing invasive carcinoma.  Dis Colon Rectum . 1992;  35 933-937
  • 26 Muto T, Sawada T, Sukihara K. Treatment of carcinoma in adenomas.  World J Surg . 1991;  15 35-40
  • 27 Morson B C, Whiteway J E, Jones E A. Histopathology and prognosis of malignant colorectal polyps treated by endoscopic polypectomy.  Gut . 1984;  25 437-444
  • 28 Kikuchi R, Takano M, Takagi K. Management of early invasive colorectal cancer. Risk of recurrence and clinical guidelines.  Dis Colon Rectum . 1995;  38 1286-1295
  • 29 Eberhart C E, Coffey R J, Radhika A. Up-regulation of cyclo-oxygenase2 gene expression in human colorectal adenomas and adenocarcinomas.  Gastroenterology . 1994;  107 1183-1188
  • 30 Mackawa M, Sugaro K, Sano H. Increased expression of cyclo-oxygenase -2 to -1 in human colorectal cancers and adenomas, but not in hyperplastic polyps.  Jpn J Clin Oncol . 1998;  28 421-426
  • 31 Richter M, Weiss M, Weinberger I, Furstenberger G, Marian B. Growth inhibition and induction of apoptosis in colorectal tumor cells by cyclo-oxygenase inhibitors.  Carcinogensis . 2001;  22 17-25
  • 32 Jacoby R F, Seiber K, Cole C E. The cyclo-oxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis.  Cancer Res . 2000;  60 5040-5044
  • 33 Oshima M, Murai N, Kargman S. Chemoprevention of intestinal polyposis in the APC-716 mouse by rofecoxib, a specific cyclo-oxygenase-2 inhibitor.  Cancer Res . 2001;  61 1733-1740